$2.16 -0.14 (-6.28%)
2/10/2012 4:00 PM

Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Featured Broker Partners


Advertisement